Skip to main content

Table 2 Secondary endpoints

From: Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer

   • Local control and recurrence patterns of pancreatic cancer
   • Progression free survival
   • Radiation related toxicity
   • Surgical morbidity in patients who received this protocol treatment
   • 30 day postoperative mortality
   • Quality of life according to EORTC QoL questionnaire after 3 and 6 months
   • Plasma proteomics
   • Whole blood transcriptomics